Markers of Aggressiveness in Pituitary Tumors: Update and Perspectives
暂无分享,去创建一个
S. Grottoli | F. Bioletto | N. Prencipe | C. Bona | A. Berton | E. Varaldo
[1] Kai Shu,et al. Classifying Pituitary Adenoma Invasiveness Based on Radiological, Surgical and Histological Features: A Retrospective Assessment of 903 Cases , 2022, Journal of clinical medicine.
[2] S. Asa,et al. Overview of the 2022 WHO Classification of Pituitary Tumors , 2022, Endocrine Pathology.
[3] P. Kober,et al. Invasive and Noninvasive Nonfunctioning Gonadotroph Pituitary Tumors Differ in DNA Methylation Level of LINE-1 Repetitive Elements , 2021, Journal of clinical medicine.
[4] J. Ostrowski,et al. Differential microRNA Expression in USP8-Mutated and Wild-Type Corticotroph Pituitary Tumors Reflect the Difference in Protein Ubiquitination Processes , 2021, Journal of clinical medicine.
[5] R. Luque,et al. Quantitative Analysis of Somatostatin and Dopamine Receptors Gene Expression Levels in Non-functioning Pituitary Tumors and Association with Clinical and Molecular Aggressiveness Features , 2020, Journal of clinical medicine.
[6] C. Lamas,et al. Differential Expression of MicroRNAs in Silent and Functioning Corticotroph Tumors , 2020, Journal of clinical medicine.
[7] M. Toda,et al. Analysis of Tumor Angiogenesis and Immune Microenvironment in Non-Functional Pituitary Endocrine Tumors , 2019, Journal of clinical medicine.
[8] O. Dekkers,et al. European Society of Endocrinology Clinical Practice Guidelines for the management of aggressive pituitary tumours and carcinomas. , 2018, European journal of endocrinology.